Oramed Pharmaceuticals Inc. (ORMP)

Price & Market Data

Price: $4.40

Daily Change: -$0.22 / 5.00%

Daily Range: $4.35 - $4.64

Market Cap: $179,985,488

Daily Volume: 156,420

Performance Metrics

1 Week: 11.81%

1 Month: 17.41%

3 Months: 31.66%

6 Months: 118.0%

1 Year: 113.1%

YTD: 67.49%

About Oramed Pharmaceuticals Inc. (ORMP)

Daily market data for Oramed Pharmaceuticals Inc. (ORMP). Current price: 4.40, daily change: -$0.22 / 5.00%. Market cap: 179,985,488. Performance 1-week and 52-week.

Company Details

Employees: 13

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.

Selected stocks

urban-gro, Inc. (UGRO)

Ebang International Holdings Inc. (EBON)

Nuveen Municipal Credit Opportunities Fund (NMCO)

Worthington Steel, Inc. (WS)

Kyivstar Group Ltd. (KYIV)